Literature DB >> 11823075

A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study.

Patrick W Serruys1, David P Foley, Martin Jan Suttorp, Benno J W M Rensing, Harry Suryapranata, Phillipe Materne, Arijan van den Bos, Edouard Benit, Angelo Anzuini, Wolfgang Rutsch, Victor Legrand, Keith Dawkins, Michael Cobaugh, Marco Bressers, Bianca Backx, William Wijns, Antonio Colombo.   

Abstract

OBJECTIVES: We sought to investigate the clinical benefit of additional stent implantation after achieving an optimal result of balloon angioplasty (BA) in long coronary lesions (>20 mm).
BACKGROUND: Long coronary lesions are associated with increased early complications and late restenosis after BA. Stenting improves the early outcome, but stent restenosis is also related to both lesion length and stent length.
METHODS: A total of 437 patients with a single native lesion 20 to 50 mm in length were included and underwent BA, using long balloons matched to lesion length and vessel diameter (balloon/artery ratio 1.1) to achieve a diameter stenosis (DS) <30% by on-line quantitative coronary angiography (QCA). "Bail-out stenting" was performed for flow-limiting dissections or >50% DS. Patients in whom an optimal BA result was achieved were randomized to additional stenting (using NIR stents) or no stenting. The primary end point was freedom from major adverse cardiac events (MACE) at nine months, and core laboratory QCA was performed on serial angiograms.
RESULTS: Bailout stenting was necessary in 149 patients (34%) and was associated with a significantly increased risk of peri-procedural infarction (p < 0.02). Among the 288 randomized patients, the mean lesion length was 27+/-9 mm, and the vessel diameter was 2.78+/-0.52 mm. The procedural success rate was 90% for the 143 patients assigned to BA alone (control group), as compared with 93% in the 145 patients assigned to additional stenting (stent group), which resulted in a superior early minimal lumen diameter (0.54 mm, p < 0.001) and led to reduced angiographic restenosis (27% vs. 42%, p = 0.022). Freedom from MACE at nine months was 77% in both groups.
CONCLUSIONS: A strategy of provisional stenting for long coronary lesions led to bailout stenting in one-third of patients, with a threefold increase in peri-procedural infarction. Additional stenting yielded a lower angiographic restenosis rate, but no reduction in MACE at nine months.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823075     DOI: 10.1016/s0735-1097(01)01760-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Contemporary Use of Drug-eluting Stents.

Authors:  William W Chu; Ron Waksman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

2.  Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach.

Authors:  David M Kent; Thomas A Trikalinos
Journal:  Am Heart J       Date:  2008-01-18       Impact factor: 4.749

3.  Assessment of in-stent restenosis using 64-MDCT: analysis of the CORE-64 Multicenter International Trial.

Authors:  Joanna J Wykrzykowska; Armin Arbab-Zadeh; Gustavo Godoy; Julie M Miller; Shezhang Lin; Andrea Vavere; Narinder Paul; Hiroyuki Niinuma; John Hoe; Jeffrey Brinker; Faisal Khosa; Sheryar Sarwar; Joao Lima; Melvin E Clouse
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

4.  Local gene delivery via endovascular stents coated with dodecylated chitosan-plasmid DNA nanoparticles.

Authors:  Dunwan Zhu; Xu Jin; Xigang Leng; Hai Wang; Junbo Bao; Wenguang Liu; Kangde Yao; Cunxian Song
Journal:  Int J Nanomedicine       Date:  2010-12-06

5.  Impact of heterogeneous overlapping drug-eluting stents on the arterial responses of rabbit iliac arteries: a comparison with overlapping bare metal stents.

Authors:  Seung-Woon Rha; Kang-Yin Chen; Dong Joo Oh; Yong-Jian Li; Zhe Jin; Kanhaiya Lal Poddar; Sureshkumar Ramasamy; Yoshiyasu Minami; Amro Elnagar; Byoung Geol Choi; Sang Pyo Hong; Byoung Won Cheon; Sang Ki Moon; Sung Il Im; Sun Won Kim; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Jin Won Kim; Eung Ju Kim; Seong Woo Han; Chang Gyu Park; Hong Seog Seo; Jung Ha Kim; Young Joon Hong; Myung Ho Jeong
Journal:  Korean Circ J       Date:  2012-06-28       Impact factor: 3.243

6.  Impact of the distance from the stent edge to the residual plaque on edge restenosis following everolimus-eluting stent implantation.

Authors:  Masao Takahashi; Susumu Miyazaki; Masahiro Myojo; Daigo Sawaki; Hiroshi Iwata; Arihiro Kiyosue; Yasutomi Higashikuni; Tomofumi Tanaka; Daishi Fujita; Jiro Ando; Hideo Fujita; Yasunobu Hirata; Issei Komuro
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

7.  Percutaneous coronary intervention using a full metal jacket with drug-eluting stents: major adverse cardiac events at one year.

Authors:  Rita Calé; Rui Campante Teles; Manuel Almeida; Ingrid do Rosário; Pedro Jerónimo Sousa; João Brito; Luís Raposo; Pedro de Araújo Gonçalves; Henrique Mesquita Gabriel; Miguel Mendes
Journal:  Arq Bras Cardiol       Date:  2013-07-02       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.